Cargando…
Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis
BACKGROUND: Citation bias occurs when positive trials involving a medical intervention receive more citations than neutral or negative trials of similar quality. Several large clinical trials have studied the use of thrombolytic agents for the treatment of acute ischemic stroke with differing result...
Autores principales: | Misemer, Benjamin S., Platts-Mills, Timothy F., Jones, Christopher W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039798/ https://www.ncbi.nlm.nih.gov/pubmed/27677444 http://dx.doi.org/10.1186/s13063-016-1595-7 |
Ejemplares similares
-
Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011) -
Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study
por: Jones, Christopher W, et al.
Publicado: (2018) -
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023) -
Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010) -
Thrombolytic or endovascular therapy for acute ischemic stroke: Time is brain
por: Mijajlovic, Milija D.
Publicado: (2014)